Compounds > sb 203580
Page last updated: 2024-09-05

sb 203580 and Burkitt Lymphoma

sb 203580 has been researched along with Burkitt Lymphoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, JB; Liu, ZS; Luo, ZQ; Xiao, Y; Xie, B; Xue, QF; Yang, ZS1
Bonavida, B; Garban, H; Huerta-Yepez, S; Jazirehi, AR; Vega, MI1
Horie, K; Ohashi, M; Sairenji, T; Satoh, Y1
Buttgereit, P; Haier, B; Kube, D; Tesch, H; Vockerodt, M1

Other Studies

4 other study(ies) available for sb 203580 and Burkitt Lymphoma

ArticleYear
[Effect and mechanism of matrine on apoptosis of Raji cells].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2011, Volume: 34, Issue:4

    Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Burkitt Lymphoma; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Flow Cytometry; Humans; Imidazoles; Matrines; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Quinolizines; Signal Transduction; Up-Regulation

2011
Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
    Oncogene, 2005, Dec-08, Volume: 24, Issue:55

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; fas Receptor; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Lymphoma, AIDS-Related; Lymphoma, B-Cell; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Rituximab; Transcription, Genetic

2005
The role of p38 mitogen-activated protein kinase in regulating interleukin-10 gene expression in Burkitt's lymphoma cell lines.
    Microbiology and immunology, 2007, Volume: 51, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Burkitt Lymphoma; Cell Line; Enzyme Inhibitors; Gene Expression; Humans; Imidazoles; Interleukin-10; Janus Kinase 1; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Receptors, Interleukin-10; RNA, Messenger; TYK2 Kinase

2007
The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.
    Virology, 2001, Feb-15, Volume: 280, Issue:2

    Topics: Binding Sites; Burkitt Lymphoma; CD40 Antigens; Enzyme Inhibitors; fas Receptor; Gene Expression; Hodgkin Disease; Humans; Imidazoles; Immunomagnetic Separation; Intercellular Adhesion Molecule-1; Interleukin-10; Jurkat Cells; Lymphoma; Mitogen-Activated Protein Kinases; Mitogens; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction; Tetradecanoylphorbol Acetate; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Viral Matrix Proteins

2001